Literature DB >> 20442322

Acute elevation of plasma lipids does not affect ATP synthesis in human skeletal muscle.

A Brehm1, M Krssák, A I Schmid, P Nowotny, W Waldhäusl, M Roden.   

Abstract

Prolonged elevation of plasma triglycerides and free fatty acids (FFA) reduces insulin-stimulated glucose disposal and myocellular flux through ATP synthase (fATPase). However, the early effects of lipids per se on fATPase are as yet unclear. Thus, this study examined glucose disposal and fATPase during 3 h of FFA elevation in the presence of low plasma insulinemia. Euglycemic pancreatic clamps with low-dose insulin supplementation (6 mU.m body surface area(-2).min(-1)) were performed in eight healthy men with (LIP) or without (CON) lipid infusion to measure whole body glucose disposal. (31)P/(1)H magnetic resonance spectroscopy of calf muscle was applied to quantify fATPase and concentrations of glucose 6-phosphate (G6P), inorganic phosphate (P(i)), phosphocreatine (PCr), ADP, pH, and IMCL before and during the clamps. Lipid infusion increased plasma FFA approximately twofold and decreased glucose disposal by approximately 50% (110-180 min: LIP 0.87 +/- 0.45 vs. CON 1.75 +/- 0.42 mg.kg(-1).min(-1), P = 0.002; means +/- SD). Intramyocellular G6P tended to rise only under control conditions, whereas PCr, ADP, pH, and IMCL remained unchanged from fasting in LIP and CON. Although P(i) concentrations increased by approximately 18%, fATPase remained unchanged from fasting during the clamps (LIP 10.2 +/- 2.2 vs. CON 10.5 +/- 2.6 micromol.g muscle(-1).min(-1), P = not significant). We conclude that 3 h of lipid elevation fail to affect ATP synthesis despite marked reduction of whole body glucose uptake. This suggests that lipid-induced insulin resistance results primarily from mechanisms decreasing glucose uptake rather than from direct interference of fatty acid metabolites with mitochondrial function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20442322     DOI: 10.1152/ajpendo.00756.2009

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  17 in total

Review 1.  The role of mitochondria in insulin resistance and type 2 diabetes mellitus.

Authors:  Julia Szendroedi; Esther Phielix; Michael Roden
Journal:  Nat Rev Endocrinol       Date:  2011-09-13       Impact factor: 43.330

2.  Metabolic Effects of Long-Term Reduction in Free Fatty Acids With Acipimox in Obesity: A Randomized Trial.

Authors:  Hideo Makimura; Takara L Stanley; Caroline Suresh; Ana Luisa De Sousa-Coelho; Walter R Frontera; Stephanie Syu; Laurie R Braun; Sara E Looby; Meghan N Feldpausch; Martin Torriani; Hang Lee; Mary-Elizabeth Patti; Steven K Grinspoon
Journal:  J Clin Endocrinol Metab       Date:  2015-12-21       Impact factor: 5.958

Review 3.  Mitochondrial plasticity in obesity and diabetes mellitus.

Authors:  Tomas Jelenik; Michael Roden
Journal:  Antioxid Redox Signal       Date:  2012-10-09       Impact factor: 8.401

4.  Reduction of non-esterified fatty acids improves insulin sensitivity and lowers oxidative stress, but fails to restore oxidative capacity in type 2 diabetes: a randomised clinical trial.

Authors:  Esther Phielix; Tomas Jelenik; Peter Nowotny; Julia Szendroedi; Michael Roden
Journal:  Diabetologia       Date:  2013-12-06       Impact factor: 10.122

5.  Cardiomyocyte lipids impair β-adrenergic receptor function via PKC activation.

Authors:  Konstantinos Drosatos; Kalyani G Bharadwaj; Anastasios Lymperopoulos; Shota Ikeda; Raffay Khan; Yunying Hu; Rajiv Agarwal; Shuiqing Yu; Hongfeng Jiang; Susan F Steinberg; William S Blaner; Walter J Koch; Ira J Goldberg
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-12-07       Impact factor: 4.310

6.  Inhibition of lipolysis in Type 2 diabetes normalizes glucose disposal without change in muscle glycogen synthesis rates.

Authors:  Ee L Lim; Kieren G Hollingsworth; Fiona E Smith; Peter E Thelwall; Roy Taylor
Journal:  Clin Sci (Lond)       Date:  2011-08       Impact factor: 6.124

7.  Vascular effects of intravenous intralipid and dextrose infusions in obese subjects.

Authors:  Aidar R Gosmanov; Dawn D Smiley; Limin Peng; Joselita Siquiera; Gonzalo Robalino; Christopher Newton; Guillermo E Umpierrez
Journal:  Metabolism       Date:  2012-04-05       Impact factor: 8.694

8.  Role of diacylglycerol activation of PKCθ in lipid-induced muscle insulin resistance in humans.

Authors:  Julia Szendroedi; Toru Yoshimura; Esther Phielix; Chrysi Koliaki; Mellissa Marcucci; Dongyan Zhang; Tomas Jelenik; Janette Müller; Christian Herder; Peter Nowotny; Gerald I Shulman; Michael Roden
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-16       Impact factor: 11.205

Review 9.  What do magnetic resonance-based measurements of Pi→ATP flux tell us about skeletal muscle metabolism?

Authors:  Graham J Kemp; Kevin M Brindle
Journal:  Diabetes       Date:  2012-08       Impact factor: 9.461

Review 10.  ³¹P-magnetization transfer magnetic resonance spectroscopy measurements of in vivo metabolism.

Authors:  Douglas E Befroy; Douglas L Rothman; Kitt Falk Petersen; Gerald I Shulman
Journal:  Diabetes       Date:  2012-11       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.